Copeptin is not associated with menstrual cycle hormones

C. Blum; U. Mirza; M. Christ-Crain; B. Mueller; J. Puder

P1446

Prev Next

Section Contents Cite

Endocrine Abstracts (2012) 29 P1446

ICEECE2012 Poster Presentations Pituitary Clinical (183 abstracts)

Copeptin is not associated with menstrual cycle hormones

C. Blum ^1, , U. Mirza ¹ , M. Christ-Crain ² , B. Mueller ¹ & J. Puder ³

Err

Author affiliations

¹Kantonsspital Aarau AG, Aarau, Switzerland; ²University Hospital Basel, Basel, Switzerland; ³University Hospital Lausanne (CHUV), Lausanne, Switzerland.

Background: Copeptin (CP), a derivate from the antidiuretic hormone (ADH) precursor pre-pro-vasopressin, stochiometrically mirrors ADH secretion. CP is increasingly evaluated as a diagnostic and prognostic biomarker in different diseases. It is therefore important to recognize possible confounding factors when interpreting CP levels. In healthy regularly menstruating women, there is a small but measurable physiological variability of hormones involved in fluid regulation. ADH plasma levels have been found to be lowest at menstruation, increasing during the follicular phase with a peak at ovulation and a drop in the luteal phase.

We investigated the variability of CP during the menstrual cycle (MC) and its correlation to MC hormones.

Methods: In total, 15 healthy women with regular MC (from 26 to 33 days) were included in this study. Ovulation was confirmed by progesterone (prog) levels on day 21 of the MC before entering the study and during the study. Blood collection was performed on days 3, 5, 8–16, 18, 21, 24 and 27 of their MC. Serums were assayed for prog, estradiol (E₂), LH, and CP. Mixed linear regression analysis for repeated measures was performed to study the changes of CP, prog, E₂ and LH during the MC, and to test the correlation of CP with sex hormones during the MC.

Results: Mean MC length in all subjects was 28.5±2.2 d. E₂, prog, and LH exhibited characteristic changes during the MC (all P< 0.05). All cycles were ovulatory (peak prog 54±15 nmol/l). CP levels did not change significantly throughout the MC, and were not associated with changes in prog, E₂ or LH-levels (all P=ns).

Conclusion: CP levels remain stable during the MC and are not influenced by changes in sex hormones. This implicates that it is not necessary to consider MC phases when using CP as a biomarker in premenopausal women.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This work was supported, however, funding details unavailable.